Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

SENSCIS Trial Investigators, Hyun J Kim

Research output: Contribution to journalArticlepeer-review

926 Scopus citations

Fingerprint

Dive into the research topics of 'Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences